Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
358
datasets available to search
ShareScore release 0.9.0
Dataset results
358 results for “SAR studies”
Population-based, Age- and Gender- Stratified Sero-Survey Study for SARS-CoV-2 in Uganda
<p>Results of population-based age stratified seroepidemiological investigation in Uganda</p>
Interaction of Surface Glycoprotein of SARS-CoV-2 Variants of Concern with Potential Drug Candidates: A Molecular Docking Study
<p>This dataset contains additional docking images of SARS-CoV-2 Variants of Concern with drugs under study. It also contains a spreadsheet containing binding residues with different types of bonds. Further it includes the raw spike protein sequences, 3D model of spike proteins of VOCs (variant of concern) and potential drugs used in this study. </p>
Data set for "SARS-CoV-2 introductions to the island of Ireland: a phylogenetic and geospatiotemporal study of infection dynamics"
<p>Please see README.txt for detailed information about the contents of this data repository.</p>
Dataset for a study:Clinical characteristics of SARS-CoV-2 delta variant infection in Xiamen
<p>This retrospective study aims to identify the clinical and demographic features of patients infected with the SARS-CoV-2 delta variant at a single institution in Xiamen, China.</p>
Evaluation of oxidative stress markers in Rwanda during the SARS-CoV-2 pandemic: a cross-sectional study
<p>SARS-CoV-2 is mainly described as endothelial dysfunction, and due to the bidirectional link between oxidative stress and endothelial dysfunction, we initiated a program directed to the evaluation of the oxidative status of the population of Rwanda by measuring spectrophotometrically their plasma Reactive Oxygen Metabolites (dROMs) and Plasma Antioxidant Potential (PAT). The reference population was chosen to reflect the absence of actual or past SARS-CoV-2 infections as well as other clinically established infective status and reference intervals for d-ROM and PAT were identified.</p> <p>The average d-ROM was 378.6 UCARR with a standard deviation of 105.2. The average PAT value was 2853.6, with a standard deviation of 635.7 UCOR. On the basis of the published values for the Caucasian and East Asian populations, the average value of d-ROM obtained in Rwanda was significantly higher than expected. Conversely, the average PAT value was at the upper limit according to the averaged values for healthy Caucasian populations. The results of this study, the first so far reported on a sub-Saharan population, can effectively be used as a baseline value for clinical management of inflammatory conditions, for the stratification of at-risk individuals and to inform recommendations for effective use of public health resources.</p>
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
ClinicalTrials.gov study NCT00926185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children
ClinicalTrials.gov study NCT04448717. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Singapore SARS-CoV-2 Human Challenge Study
ClinicalTrials.gov study NCT06654973. IPD Sharing: NO. Countries: 1. Publications: 2.
Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects
ClinicalTrials.gov study NCT04671017. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
ClinicalTrials.gov study NCT04602000. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults
ClinicalTrials.gov study NCT04614948. IPD Sharing: YES. Countries: 10. Publications: 1.
A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine
ClinicalTrials.gov study NCT04811664. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
ClinicalTrials.gov study NCT04375397. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
ClinicalTrials.gov study NCT05168813. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
ClinicalTrials.gov study NCT06097273. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity Afte
ClinicalTrials.gov study NCT05567952. IPD Sharing: YES. Countries: 5. Publications: 2.
VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
ClinicalTrials.gov study NCT04842747. IPD Sharing: NO. Countries: 6. Publications: 1.
A Study of Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Been Infected by SARS-COV-2
ClinicalTrials.gov study NCT06601920. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
ClinicalTrials.gov study NCT05827926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
ClinicalTrials.gov study NCT04785144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.